Insight into the practical performance of RT-PCR testing for SARS-CoV-2 using serological data: a cohort study.


Journal

The Lancet. Microbe
ISSN: 2666-5247
Titre abrégé: Lancet Microbe
Pays: England
ID NLM: 101769019

Informations de publication

Date de publication:
02 2021
Historique:
pubmed: 27 1 2021
medline: 27 1 2021
entrez: 26 1 2021
Statut: ppublish

Résumé

Virological detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through RT-PCR has limitations for surveillance. Serological tests can be an important complementary approach. We aimed to assess the practical performance of RT-PCR-based surveillance protocols and determine the extent of undetected SARS-CoV-2 infection in Shenzhen, China. We did a cohort study in Shenzhen, China and attempted to recruit by telephone all RT-PCR-negative close contacts (defined as those who lived in the same residence as, or shared a meal, travelled, or socially interacted with, an index case within 2 days before symptom onset) of all RT-PCR-confirmed cases of SARS-CoV-2 detected since January, 2020, via contact tracing. We measured anti-SARS-CoV-2 antibodies in serum samples from RT-PCR-negative close contacts 2-15 weeks after initial virological testing by RT-PCR, using total antibody, IgG, and IgM ELISAs. In addition, we did a serosurvey of volunteers from neighbourhoods with no reported cases, and from neighbourhoods with reported cases. We assessed rates of infection undetected by RT-PCR, performance of RT-PCR over the course of infection, and characteristics of individuals who were seropositive on total antibody ELISA but RT-PCR negative. Between April 12 and May 4, 2020, we enrolled and collected serological samples from 2345 (53·0%) of 4422 RT-PCR-negative close contacts of cases of RT-PCR-confirmed SARS-CoV-2. 1175 (50·1%) of 2345 were close contacts of cases diagnosed in Shenzhen with contact tracing details, and of these, 880 (74·9%) had serum samples collected more than 2 weeks after exposure to an index case and were included in our analysis. 40 (4·5%) of 880 RT-PCR-negative close contacts were positive on total antibody ELISA. The seropositivity rate with total antibody ELISA among RT-PCR-negative close contacts, adjusted for assay performance, was 4·1% (95% CI 2·9-5·7), which was significantly higher than among individuals residing in neighbourhoods with no reported cases (0·0% [95% CI 0·0-1·1]). RT-PCR-positive individuals were 8·0 times (95% CI 5·3-12·7) more likely to report symptoms than those who were RT-PCR-negative but seropositive, but both groups had a similar distribution of sex, age, contact frequency, and mode of contact. RT-PCR did not detect 48 (36% [95% CI 28-44]) of 134 infected close contacts, and false-negative rates appeared to be associated with stage of infection. Even rigorous RT-PCR testing protocols might miss a substantial proportion of SARS-CoV-2 infections, perhaps in part due to difficulties in determining the timing of testing in asymptomatic individuals for optimal sensitivity. RT-PCR-based surveillance and control protocols that include rapid contact tracing, universal RT-PCR testing, and mandatory 2-week quarantine were, nevertheless, able to contain community spread in Shenzhen, China. The Bill & Melinda Gates Foundation, Special Foundation of Science and Technology Innovation Strategy of Guangdong Province, and Key Project of Shenzhen Science and Technology Innovation Commission.

Sections du résumé

BACKGROUND
Virological detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through RT-PCR has limitations for surveillance. Serological tests can be an important complementary approach. We aimed to assess the practical performance of RT-PCR-based surveillance protocols and determine the extent of undetected SARS-CoV-2 infection in Shenzhen, China.
METHODS
We did a cohort study in Shenzhen, China and attempted to recruit by telephone all RT-PCR-negative close contacts (defined as those who lived in the same residence as, or shared a meal, travelled, or socially interacted with, an index case within 2 days before symptom onset) of all RT-PCR-confirmed cases of SARS-CoV-2 detected since January, 2020, via contact tracing. We measured anti-SARS-CoV-2 antibodies in serum samples from RT-PCR-negative close contacts 2-15 weeks after initial virological testing by RT-PCR, using total antibody, IgG, and IgM ELISAs. In addition, we did a serosurvey of volunteers from neighbourhoods with no reported cases, and from neighbourhoods with reported cases. We assessed rates of infection undetected by RT-PCR, performance of RT-PCR over the course of infection, and characteristics of individuals who were seropositive on total antibody ELISA but RT-PCR negative.
FINDINGS
Between April 12 and May 4, 2020, we enrolled and collected serological samples from 2345 (53·0%) of 4422 RT-PCR-negative close contacts of cases of RT-PCR-confirmed SARS-CoV-2. 1175 (50·1%) of 2345 were close contacts of cases diagnosed in Shenzhen with contact tracing details, and of these, 880 (74·9%) had serum samples collected more than 2 weeks after exposure to an index case and were included in our analysis. 40 (4·5%) of 880 RT-PCR-negative close contacts were positive on total antibody ELISA. The seropositivity rate with total antibody ELISA among RT-PCR-negative close contacts, adjusted for assay performance, was 4·1% (95% CI 2·9-5·7), which was significantly higher than among individuals residing in neighbourhoods with no reported cases (0·0% [95% CI 0·0-1·1]). RT-PCR-positive individuals were 8·0 times (95% CI 5·3-12·7) more likely to report symptoms than those who were RT-PCR-negative but seropositive, but both groups had a similar distribution of sex, age, contact frequency, and mode of contact. RT-PCR did not detect 48 (36% [95% CI 28-44]) of 134 infected close contacts, and false-negative rates appeared to be associated with stage of infection.
INTERPRETATION
Even rigorous RT-PCR testing protocols might miss a substantial proportion of SARS-CoV-2 infections, perhaps in part due to difficulties in determining the timing of testing in asymptomatic individuals for optimal sensitivity. RT-PCR-based surveillance and control protocols that include rapid contact tracing, universal RT-PCR testing, and mandatory 2-week quarantine were, nevertheless, able to contain community spread in Shenzhen, China.
FUNDING
The Bill & Melinda Gates Foundation, Special Foundation of Science and Technology Innovation Strategy of Guangdong Province, and Key Project of Shenzhen Science and Technology Innovation Commission.

Identifiants

pubmed: 33495759
doi: 10.1016/S2666-5247(20)30200-7
pii: S2666-5247(20)30200-7
pmc: PMC7816573
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

e79-e87

Informations de copyright

© 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.

Références

Clin Infect Dis. 2020 Nov 19;71(16):2027-2034
pubmed: 32221519
Lancet Infect Dis. 2020 Aug;20(8):911-919
pubmed: 32353347
Influenza Other Respir Viruses. 2017 Nov;11(6):511-517
pubmed: 28799710
PLoS One. 2020 Dec 10;15(12):e0242958
pubmed: 33301459
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
BMJ. 2020 Jul 1;370:m2516
pubmed: 32611558
Sci Immunol. 2020 Oct 8;5(52):
pubmed: 33033172
Clin Chem Lab Med. 2020 Aug 31;58(12):2131-2140
pubmed: 32866113
Sci Immunol. 2020 May 19;5(47):
pubmed: 32430309
Nat Med. 2020 Jun;26(6):845-848
pubmed: 32350462
Nat Commun. 2020 Jul 6;11(1):3436
pubmed: 32632160
Lancet Infect Dis. 2020 Jun;20(6):635-636
pubmed: 32224308
JAMA. 2019 Sep 3;322(9):824-833
pubmed: 31479137
Ann Intern Med. 2020 Aug 18;173(4):262-267
pubmed: 32422057
Int J Epidemiol. 1996 Dec;25(6):1107-16
pubmed: 9027513
JAMA. 2020 Apr 21;323(15):1502-1503
pubmed: 32105304
IARC Sci Publ. 1980;(32):5-338
pubmed: 7216345

Auteurs

Zhen Zhang (Z)

Department of Public Health Information, Shenzhen Center for Disease Control and Prevention, Shenzhen, China.

Qifang Bi (Q)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Shisong Fang (S)

Department of Pathogenic Biology, Shenzhen Center for Disease Control and Prevention, Shenzhen, China.

Lan Wei (L)

Department of Public Health Information, Shenzhen Center for Disease Control and Prevention, Shenzhen, China.

Xin Wang (X)

Department of Pathogenic Biology, Shenzhen Center for Disease Control and Prevention, Shenzhen, China.

Jianfan He (J)

Shenzhen Center for Disease Control and Prevention, Shenzhen, China.

Yongsheng Wu (Y)

Department of Public Health Information, Shenzhen Center for Disease Control and Prevention, Shenzhen, China.

Xiaojian Liu (X)

Department of Public Health Information, Shenzhen Center for Disease Control and Prevention, Shenzhen, China.

Wei Gao (W)

Department of Communicable Diseases Control and Prevention, Shenzhen Center for Disease Control and Prevention, Shenzhen, China.

Renli Zhang (R)

Department of Pathogenic Biology, Shenzhen Center for Disease Control and Prevention, Shenzhen, China.

Wenfeng Gong (W)

The Bill & Melinda Gates Foundation, Seattle, WA, USA.

Qiru Su (Q)

Pediatric Research Institute, Shenzhen Children's Hospital, Shenzhen, China.

Andrew S Azman (AS)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Justin Lessler (J)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Xuan Zou (X)

Shenzhen Center for Disease Control and Prevention, Shenzhen, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH